Overview HEPSERA Post Marketing Surveillance Status: Completed Trial end date: 2010-02-01 Target enrollment: Participant gender: Summary An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and/or efficacy of adefovir dipivoxil administered in Korean CHB patients according to the prescribing information Details Lead Sponsor: GlaxoSmithKlineTreatments: AdefovirAdefovir dipivoxil